The potential benefits of shRNA-mediated MMP1 silencing for psoriasis

DOI: 10.5584/jiomics.v9i1.269

Authors

  • Julia Mogulevtseva Timiryazev Russian Agrarian University, Russia
  • Sergey Bruskin National N.I. Vavilov Institute of General Genetics, Russian Academy of Sciences, Russia
  • Alexandre Mezentsev National N.I. Vavilov Institute of General Genetics, Russian Academy of Sciences, Russia

Abstract

 

Matrix metalloproteinases (MMPs) orchestrate structural remodeling of psoriatic skin and accelerate the development of the inflammatory response.

In this paper, we explore whether knocking MMP1 down in epidermal keratinocytes can be beneficial for psoriasis.

We discovered that MMP1 silencing with specific shRNA reduced the migration of epidermal keratinocytes and made the cells susceptible to apoptosis in the presence of interferon-γ. Furthermore, MMP1-deficiency partially normalized the expression of genes involved in the pathogenesis of psoriasis (MMP9, -12, CCNA2, CCND1 and KRT17) and the terminal differentiation (KRT1, -10, IVL and LOR).

In this respect, MMP1 silencing could be beneficial for psoriasis due to MMP1 expression is limited to psoriatic plaques and correlates with disease severity.

Downloads

Published

2021-03-08

Issue

Vol. 9 No. 1 (2019): Vol. 9, No. 1 (2019)

Section

Articles